CDC’s new vaccine advisers recommend splitting up MMRV shot - Roll Call The change was backed by an advisory panel whose members were handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. Roll Call · Sep 18, 2025
Kennedy's advisory panel is expected to vote on hepatitis B and MMRV vaccines Health Secretary Robert F The Independent UK · Sep 18, 2025
Crunch time arrives for RFK Jr.'s vaccine advisers Critics think the two days of meetings will rubber-stamp additional limits on who can get routine shots. Axios · Sep 18, 2025
RFK's handpicked advisers are coming for the childhood vaccine schedule. Here's what to know. The Advisory Committee on Immunization Practices may vote to disrupt the childhood vaccine schedule, despite what experts say is a lack of evidence to do so. LiveScience · Sep 18, 2025
US Vaccine Panel To Hold High-stakes Policy Meeting A US panel stacked with figures sympathetic to the anti-vaccine movement will on Thursday take on federal immunization recommendations in a highly politicized meeting that could upend longstanding medical advice. International Business Times · Sep 18, 2025
Ex-CDC chief details agency turmoil under RFK Jr. Susan Monarez provided a window into the ongoing turmoil at the public health agency. Axios · Sep 17, 2025
GOP shows division on Kennedy during Monarez appearance - Roll Call Former CDC director said HHS Secretary Robert F. Kennedy Jr. plans to change the childhood immunization schedule later this month. Roll Call · Sep 17, 2025
Kennedy's vaccine committee plans to vote on COVID-19, hepatitis B and chickenpox shots U.S. Health Secretary Robert F The Independent UK · Sep 15, 2025
‘I only see harm coming’: Top CDC official who quit over RFK Jr policies says he fears more attacks on vaccines still to come Demetre Daskalakis warns that the new acting CDC director will only serve Robert F. Kennedy Jr The Independent UK · Aug 31, 2025
At-home hepatitis C test identifies hundreds with silent but deadly virus More than 100,000 at-home tests have been requested since the service's launch in May 2023 The Independent UK · Aug 19, 2025
At-home hepatitis C tests identify hundreds with the virus More than 100,000 of the tests have been ordered since May 2023. The Independent UK · Aug 19, 2025
EU agencies seek to combat viral hepatitis in European prisons EU agencies launch toolkit to combat hepatitis B and C in prisons, tackling drug-related transmission and implementation challenges. Euronews · Aug 8, 2025
How machine learning can help discover drugs against hepatitis C Every year, the hepatitis C virus affects more than 200 million across the world. The infection is a major cause of chronic liver disease, including chronic hepatitis, liver cirrhosis and liver cancer. Newslaundry · Aug 4, 2025
Euronews · Jul 29, 2025 Liver cancer cases could double by 2050. A new study says 60% are preventable Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver cancer cases are on the rise, the right mix of policy, prevention, and public awareness could save millions of lives.
The Guardian - UK · Jul 28, 2025 Lifestyle changes and vaccination ‘could prevent most liver cancer cases’ Lancet Commission says three in five cases preventable with action on obesity, alcohol and hepatitis
Euronews · Jul 28, 2025 Millions in Europe unknowingly living with hepatitis, health authorities warn European health authorities called for countries to improve testing, vaccination, and access to treatment.
The Guardian - AU · Jul 27, 2025 ‘Changed my life’: hepatitis treatment offers hope but not enough receiving care, report finds People like David Clune have been saved by medical breakthroughs, but many still don’t know the risks or can’t access doctors
The Independent UK · Jul 21, 2025 I’m a doctor. This is what you need to know about hepatitis. Hepatitis is a common - but misunderstood - infection
Benzinga · Jul 16, 2025 FDA Lifts Pause On Kezar's Liver Drug Trial—Next Stop Lupus Study The Division of Hepatology and Nutrition of the U.S. Food and Drug Administration lifted the partial clinical hold on Kezar Life Sciences Inc.‘s (NASDAQ:KZR) completed PORTOLA Phase 2a trial evaluating zetomipzomib in autoimmune hepatitis (AIH).
The Independent UK · Jul 15, 2025 Heading on holiday? These are the concerning symptoms you shouldn’t ignore International travel poses a risk of catching something more than a run-of-the-mill bug
The Conversation · Jul 15, 2025 Just back from holiday and not feeling well? Here are the symptoms you should take seriously Summer is synonymous with adventure, with millions flocking to exotic destinations to experience different cultures, cuisines and landscapes. But what happens when the souvenir you bring back isn’t a fridge magnet or a tea towel, but a new illness?
AAP · Jul 15, 2025 First Nations hepatitis B risks revealed in study A study of more than 700 people living with a unique strain of hepatitis B, predominantly affecting Indigenous people, has found severe risks to liver health.
Evening Standard · Jul 9, 2025 What is the infected blood scandal? It is widely regarded as the biggest treatment disaster in the history of the NHS.
The Independent UK · Jul 9, 2025 Failures in compensation scheme for infected blood laid bare in report The probe into the scandal held special hearings in May about recompense for victims.